First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
26 hedge funds and large institutions have $18.3M invested in First Trust Nasdaq Pharmaceuticals ETF in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
30.94% less ownership
Funds ownership: 81.66% → 50.72% (-31%)
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.97M | |
| 2 | +$3.01M | |
| 3 | +$1.02M | |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
+$761K |
| 5 |
KNW
Kesler Norman & Wride
Ogden,
Utah
|
+$661K |
Top Sellers
| 1 | -$6.33M | |
| 2 | -$4.21M | |
| 3 | -$652K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$507K |
| 5 |
Jane Street
New York
|
-$397K |